WallStreetZenWallStreetZen

NYSEMKT: STXS
Stereotaxis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for STXS

Based on 2 analysts offering 12 month price targets for Stereotaxis Inc

Min Forecast
$4.00+111.64%
Avg Forecast
$4.00+111.64%
Max Forecast
$4.00+111.64%

Should I buy or sell STXS stock?

Based on 2 analysts offering ratings for Stereotaxis Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although STXS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates STXS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their STXS stock forecasts and price targets.

STXS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-16
lockedlocked$00.00+00.00%2025-11-12

1 of 1

Forecast return on equity

Is STXS forecast to generate an efficient return?

Company
-78.7%
Industry
18.83%
Market
149.57%
STXS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STXS forecast to generate an efficient return on assets?

Company
-20.31%
Industry
13.89%
STXS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STXS earnings per share forecast

What is STXS's earnings per share in the next 2 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$0.19
Avg 2 year Forecast
-$0.11

STXS revenue forecast

What is STXS's revenue in the next 2 years based on estimates from 7 analysts?

Avg 1 year Forecast
$43.4M+34.08%
Avg 2 year Forecast
$58.7M+81.25%
STXS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STXS revenue growth forecast

How is STXS forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
34.08%
Industry
9.07%
Market
26.1%
STXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STXS vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
STXS$1.89$4.00+111.64%Strong Buy
MBOT$2.76$7.50+171.74%Strong Buy
SMTI$19.62$36.00+83.49%Buy
KRMD$4.27$7.33+71.73%Strong Buy
INFU$9.83$15.00+52.59%Strong Buy
View Top Medical Stocks

Stereotaxis Stock Forecast FAQ

Is Stereotaxis Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSEMKT: STXS) stock is to Strong Buy STXS stock.

Out of 2 analysts, 1 (50%) are recommending STXS as a Strong Buy, 1 (50%) are recommending STXS as a Buy, 0 (0%) are recommending STXS as a Hold, 0 (0%) are recommending STXS as a Sell, and 0 (0%) are recommending STXS as a Strong Sell.

If you're new to stock investing, here's how to buy Stereotaxis stock.

What is STXS's earnings growth forecast for 2026-2027?

(NYSEMKT: STXS) Stereotaxis's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 304.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,656.83%.

Stereotaxis's earnings in 2026 is -$22,914,000.On average, 7 Wall Street analysts forecast STXS's earnings for 2026 to be -$18,769,045, with the lowest STXS earnings forecast at -$21,919,910, and the highest STXS earnings forecast at -$12,253,366.

In 2027, STXS is forecast to generate -$10,609,859 in earnings, with the lowest earnings forecast at -$14,392,843 and the highest earnings forecast at -$6,126,683.

What is STXS's revenue growth forecast for 2026-2027?

(NYSEMKT: STXS) Stereotaxis's forecast annual revenue growth rate of 34.08% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.07%, and it is also forecast to beat the US market's average forecast revenue growth rate of 26.1%.

Stereotaxis's revenue in 2026 is $32,377,000.On average, 7 Wall Street analysts forecast STXS's revenue for 2026 to be $4,221,673,561, with the lowest STXS revenue forecast at $3,926,523,040, and the highest STXS revenue forecast at $4,543,956,535.

In 2027, STXS is forecast to generate $5,706,956,560 in revenue, with the lowest revenue forecast at $5,241,717,650 and the highest revenue forecast at $6,136,894,106.

What is STXS's forecast return on assets (ROA) for 2026-2027?

(NYSEMKT: STXS) forecast ROA is -20.31%, which is lower than the forecast US Medical Instruments & Supplies industry average of 13.89%.

What is STXS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year STXS price target, the average STXS price target is $4.00, with the highest STXS stock price forecast at $4.00 and the lowest STXS stock price forecast at $4.00.

On average, Wall Street analysts predict that Stereotaxis's share price could reach $4.00 by Dec 16, 2026. The average Stereotaxis stock price prediction forecasts a potential upside of 111.64% from the current STXS share price of $1.89.

What is STXS's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSEMKT: STXS) Stereotaxis's current Earnings Per Share (EPS) is -$0.25. On average, analysts forecast that STXS's EPS will be -$0.19 for 2026, with the lowest EPS forecast at -$0.23, and the highest EPS forecast at -$0.13. In 2027, STXS's EPS is forecast to hit -$0.11 (min: -$0.15, max: -$0.06).

What is STXS's forecast return on equity (ROE) for 2026-2027?

(NYSEMKT: STXS) forecast ROE is -78.7%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.